Icubate, Inc.
iCubate is a molecular diagnostic company dedicated to developing innovative, multiplex PCR technologies and solutions for infectious disease detection. The company focuses on creating rapid, accurate, and automated diagnostic tools, including the FDA EUA pending iC-COVID19 Assay and other multiplex assays for various pathogens. With a commitment to advancing molecular diagnostics, iCubate aims to improve healthcare outcomes through its proprietary technologies and user-friendly platforms.
Industries
Nr. of Employees
small (1-50)
Icubate, Inc.
601 Genome Way, Suite 3005, Huntsville, AL 35806
Products
Automated integrated molecular diagnostic system (processor + reader + single-use cassette)
Bench-top platform that automates sample extraction, multiplex PCR amplification, and array-based detection using a sealed single-use cassette and an instrument containing processor and reader modules.
Multiplex infectious-disease assay panels (research and regulatory statuses vary)
A menu of multiplex PCR assay panels for infectious-disease targets and resistance markers provided as consumable assay panels run on the integrated platform. Regulatory statuses include cleared, under regulatory review, EUA-pending, or research-use-only depending on the panel.
Online multiplex primer design software
Web-based design tool that incorporates melting temperature, polymerase preference indexing and multiplex PCR design rules to support development of multi-target PCR panels.
Automated integrated molecular diagnostic system (processor + reader + single-use cassette)
Bench-top platform that automates sample extraction, multiplex PCR amplification, and array-based detection using a sealed single-use cassette and an instrument containing processor and reader modules.
Multiplex infectious-disease assay panels (research and regulatory statuses vary)
A menu of multiplex PCR assay panels for infectious-disease targets and resistance markers provided as consumable assay panels run on the integrated platform. Regulatory statuses include cleared, under regulatory review, EUA-pending, or research-use-only depending on the panel.
Online multiplex primer design software
Web-based design tool that incorporates melting temperature, polymerase preference indexing and multiplex PCR design rules to support development of multi-target PCR panels.
Services
Online program enabling third-party developers to design, validate and distribute multiplex PCR assay panels via a community portal and digital store with revenue-sharing arrangements.
Coordination and execution of pre-clinical and clinical validation studies, including multi-site beta testing in hospital laboratories to assess assay performance metrics.
Online program enabling third-party developers to design, validate and distribute multiplex PCR assay panels via a community portal and digital store with revenue-sharing arrangements.
Coordination and execution of pre-clinical and clinical validation studies, including multi-site beta testing in hospital laboratories to assess assay performance metrics.
Expertise Areas
- Multiplex assay development
- Assay automation and integrated platform engineering
- Molecular diagnostics development
- Primer design algorithm development
Key Technologies
- Multiplex PCR (nested-primer and tagging strategies)
- Two-stage amplicon-rescue PCR
- Closed disposable assay cassettes
- Automated in-cassette liquid handling
News & Updates
iCubate at the 15th Annual AMP meeting
iCubate revealed its platform at the 15th Annual AMP meeting in Orlando, booth 1523.
iCubate receives Frost & Sullivan North American New Product Innovation Award
iCubate was awarded for its innovative PCR technology and rapid pathogen detection system.
iCubate wins Alabama Innovation Award
iCubate was recognized for its innovation in molecular diagnostics at the Alabama Launchpad awards.
iCubate begins clinical study of bloodstream bacteria detector
The company started clinical trials for a product to detect bacterial bloodstream infections, focusing on gram-positive bacteria.
Frost & Sullivan North American New Product Innovation Award
Recognized for innovative PCR technology and rapid detection system.
Alabama Innovation Award
Honored for innovation in molecular diagnostics.
iCubate at the 15th Annual AMP meeting
iCubate revealed its platform at the 15th Annual AMP meeting in Orlando, booth 1523.
iCubate receives Frost & Sullivan North American New Product Innovation Award
iCubate was awarded for its innovative PCR technology and rapid pathogen detection system.
iCubate wins Alabama Innovation Award
iCubate was recognized for its innovation in molecular diagnostics at the Alabama Launchpad awards.
iCubate begins clinical study of bloodstream bacteria detector
The company started clinical trials for a product to detect bacterial bloodstream infections, focusing on gram-positive bacteria.
Frost & Sullivan North American New Product Innovation Award
Recognized for innovative PCR technology and rapid detection system.
Alabama Innovation Award
Honored for innovation in molecular diagnostics.